Cargando…
Comparison of Fixed versus Calculated Activity of Radioiodine for the Treatment of Graves Disease in Adults
BACKGROUND: Radioactive iodine as a treatment modality has been shown in several studies to be a safe and effective therapy for Graves disease. However, there is still no uniformity regarding optimal dosing method. The aim of this study is to compare the efficacy of calculated and fixed dosing of ra...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Endocrine Society
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4803554/ https://www.ncbi.nlm.nih.gov/pubmed/26996425 http://dx.doi.org/10.3803/EnM.2016.31.1.168 |
_version_ | 1782422884386340864 |
---|---|
author | Canto, Abigail U. Dominguez, Paulette N. Jimeno, Cecilia A. Obaldo, Jerry M. Ogbac, Ruben V. |
author_facet | Canto, Abigail U. Dominguez, Paulette N. Jimeno, Cecilia A. Obaldo, Jerry M. Ogbac, Ruben V. |
author_sort | Canto, Abigail U. |
collection | PubMed |
description | BACKGROUND: Radioactive iodine as a treatment modality has been shown in several studies to be a safe and effective therapy for Graves disease. However, there is still no uniformity regarding optimal dosing method. The aim of this study is to compare the efficacy of calculated and fixed dosing of radioiodine for the treatment of Graves disease. METHODS: A hundred twenty-two patients diagnosed with Graves disease were randomized to receive either fixed or calculated dose of radioiodine. Those randomized to fixed activity received either low fixed activity at 9.9 mCi for thyroid gland size <40 g or high fixed activity at 14.9 mCi for thyroid gland size 40 to 80 g, and those grouped to calculated activity received 160 µCi/g of thyroid tissue adjusted for 24 hours radioiodine uptake. Thyroid function tests (free thyroxine [T4] and thyroid stimulating hormone [TSH]) were monitored at 10, 16, and 24 weeks after radioactive iodine therapy. The primary outcome, treatment failure was defined as persistently elevated free T4 and low TSH. RESULTS: Of the 122 patients randomized, 56 in the fixed dose group and 56 in the calculated dose group completed the follow-up. At the end of 6 months, the percentage of treatment failure was 37.50% in the calculated dose group versus 19.64% in the fixed dose group with a relative risk of 0.53 (95% confidence interval, 0.28 to 0.98) favoring the fixed dose group. CONCLUSION: Fixed dose radioiodine has a significantly lower incidence of persistent hyperthyroidism at 6 months post-radioactive therapy. |
format | Online Article Text |
id | pubmed-4803554 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Korean Endocrine Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-48035542016-03-27 Comparison of Fixed versus Calculated Activity of Radioiodine for the Treatment of Graves Disease in Adults Canto, Abigail U. Dominguez, Paulette N. Jimeno, Cecilia A. Obaldo, Jerry M. Ogbac, Ruben V. Endocrinol Metab (Seoul) Original Article BACKGROUND: Radioactive iodine as a treatment modality has been shown in several studies to be a safe and effective therapy for Graves disease. However, there is still no uniformity regarding optimal dosing method. The aim of this study is to compare the efficacy of calculated and fixed dosing of radioiodine for the treatment of Graves disease. METHODS: A hundred twenty-two patients diagnosed with Graves disease were randomized to receive either fixed or calculated dose of radioiodine. Those randomized to fixed activity received either low fixed activity at 9.9 mCi for thyroid gland size <40 g or high fixed activity at 14.9 mCi for thyroid gland size 40 to 80 g, and those grouped to calculated activity received 160 µCi/g of thyroid tissue adjusted for 24 hours radioiodine uptake. Thyroid function tests (free thyroxine [T4] and thyroid stimulating hormone [TSH]) were monitored at 10, 16, and 24 weeks after radioactive iodine therapy. The primary outcome, treatment failure was defined as persistently elevated free T4 and low TSH. RESULTS: Of the 122 patients randomized, 56 in the fixed dose group and 56 in the calculated dose group completed the follow-up. At the end of 6 months, the percentage of treatment failure was 37.50% in the calculated dose group versus 19.64% in the fixed dose group with a relative risk of 0.53 (95% confidence interval, 0.28 to 0.98) favoring the fixed dose group. CONCLUSION: Fixed dose radioiodine has a significantly lower incidence of persistent hyperthyroidism at 6 months post-radioactive therapy. Korean Endocrine Society 2016-03 2016-03-16 /pmc/articles/PMC4803554/ /pubmed/26996425 http://dx.doi.org/10.3803/EnM.2016.31.1.168 Text en Copyright © 2016 Korean Endocrine Society http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Canto, Abigail U. Dominguez, Paulette N. Jimeno, Cecilia A. Obaldo, Jerry M. Ogbac, Ruben V. Comparison of Fixed versus Calculated Activity of Radioiodine for the Treatment of Graves Disease in Adults |
title | Comparison of Fixed versus Calculated Activity of Radioiodine for the Treatment of Graves Disease in Adults |
title_full | Comparison of Fixed versus Calculated Activity of Radioiodine for the Treatment of Graves Disease in Adults |
title_fullStr | Comparison of Fixed versus Calculated Activity of Radioiodine for the Treatment of Graves Disease in Adults |
title_full_unstemmed | Comparison of Fixed versus Calculated Activity of Radioiodine for the Treatment of Graves Disease in Adults |
title_short | Comparison of Fixed versus Calculated Activity of Radioiodine for the Treatment of Graves Disease in Adults |
title_sort | comparison of fixed versus calculated activity of radioiodine for the treatment of graves disease in adults |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4803554/ https://www.ncbi.nlm.nih.gov/pubmed/26996425 http://dx.doi.org/10.3803/EnM.2016.31.1.168 |
work_keys_str_mv | AT cantoabigailu comparisonoffixedversuscalculatedactivityofradioiodineforthetreatmentofgravesdiseaseinadults AT dominguezpauletten comparisonoffixedversuscalculatedactivityofradioiodineforthetreatmentofgravesdiseaseinadults AT jimenoceciliaa comparisonoffixedversuscalculatedactivityofradioiodineforthetreatmentofgravesdiseaseinadults AT obaldojerrym comparisonoffixedversuscalculatedactivityofradioiodineforthetreatmentofgravesdiseaseinadults AT ogbacrubenv comparisonoffixedversuscalculatedactivityofradioiodineforthetreatmentofgravesdiseaseinadults |